Uipath [PATH] vs Amdocs [DOX] Detailed Stock Comparison

Uipath

NYSE
Loading...

Amdocs

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Uipath wins in 5 metrics, Amdocs wins in 13 metrics, with 0 ties. Amdocs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricUipathAmdocsBetter
P/E Ratio (TTM)430.0016.66Amdocs
Price-to-Book Ratio4.112.58Amdocs
Debt-to-Equity Ratio4.7623.65Uipath
PEG Ratio-4.301.20Uipath
EV/EBITDA-322.499.66Uipath
Profit Margin (TTM)1.35%11.94%Amdocs
Operating Margin (TTM)-5.19%17.69%Amdocs
EBITDA Margin (TTM)N/A17.69%N/A
Return on Equity1.15%15.73%Amdocs
Return on Assets (TTM)-0.70%7.87%Amdocs
Free Cash Flow (TTM)$305.64M$618.93MAmdocs
1-Year Return14.33%-6.59%Uipath
Price-to-Sales Ratio (TTM)4.581.95Amdocs
Enterprise Value$5.48B$9.59BAmdocs
EV/Revenue Ratio3.662.06Amdocs
Gross Profit Margin (TTM)82.20%37.86%Uipath
Revenue per Share (TTM)$3$41Amdocs
Earnings per Share (Diluted)$0.03$4.94Amdocs
Beta (Stock Volatility)1.070.52Amdocs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Uipath vs Amdocs Stock Performance Analysis

Loading Price Chart...

Uipath
Amdocs
Uipath Stock Overview | Amdocs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Uipath12.56%15.61%23.05%10.33%48.31%12.30%
Amdocs0.13%1.19%-3.93%-10.23%0.43%-2.06%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Uipath14.33%30.58%-80.60%-80.60%-80.60%-80.60%
Amdocs-6.59%4.33%40.98%40.81%175.50%212.95%

News Based Sentiment: Uipath vs Amdocs

Uipath

News based Sentiment: POSITIVE

UiPath had a very strong month, exceeding earnings expectations, forging key AI partnerships, and launching new products. While insider selling and institutional stake reductions are worth noting, the overall narrative is positive, indicating the company is well-positioned for future growth in the rapidly evolving automation market.

View Uipath News Sentiment Analysis

Amdocs

News based Sentiment: MIXED

Amdocs delivered a mixed bag in October, with a slight earnings beat and continued AI investment offset by declining revenue. The positive analyst ratings and institutional activity suggest confidence, but the revenue trend warrants close monitoring. Overall, the month presents a cautiously optimistic outlook.

View Amdocs News Sentiment Analysis

Performance & Financial Health Analysis: Uipath vs Amdocs

MetricPATHDOX
Market Information
Market Cap i$6.85B$9.09B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i24,935,740959,580
90 Day Avg. Volume i16,870,210866,193
Last Close$14.52$82.43
52 Week Range$9.38 - $15.93$78.61 - $95.41
% from 52W High-8.85%-13.60%
All-Time High$90.00 (May 24, 2021)$99.75 (Jun 26, 2023)
% from All-Time High-83.87%-17.36%
Growth Metrics
Quarterly Revenue Growth0.14%-0.08%
Quarterly Earnings Growth0.14%0.10%
Financial Health
Profit Margin (TTM) i0.01%0.12%
Operating Margin (TTM) i-0.05%0.18%
Return on Equity (TTM) i0.01%0.16%
Debt to Equity (MRQ) i4.7623.65
Cash & Liquidity
Book Value per Share (MRQ)$3.14$31.85
Cash per Share (MRQ)$2.73$3.11
Operating Cash Flow (TTM) i$334.74M$737.18M
Levered Free Cash Flow (TTM) i$449.21M$563.54M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Uipath vs Amdocs

MetricPATHDOX
Price Ratios
P/E Ratio (TTM) i430.0016.66
Forward P/E i29.3211.71
PEG Ratio i-4.301.20
Price to Sales (TTM) i4.581.95
Price to Book (MRQ) i4.112.58
Market Capitalization
Market Capitalization i$6.85B$9.09B
Enterprise Value i$5.48B$9.59B
Enterprise Value Metrics
Enterprise to Revenue i3.662.06
Enterprise to EBITDA i-322.499.66
Risk & Other Metrics
Beta i1.070.52
Book Value per Share (MRQ) i$3.14$31.85

Financial Statements Comparison: Uipath vs Amdocs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)PATHDOX
Revenue/Sales i$356.62M$1.14B
Cost of Goods Sold i$63.86M$711.15M
Gross Profit i$292.77M$433.29M
Research & Development i$94.84M$86.85M
Operating Income (EBIT) i$-16.41M$202.47M
EBITDA i$-13.16M$252.11M
Pre-Tax Income i$-19.73M$190.77M
Income Tax i$2.83M$35.96M
Net Income (Profit) i$-22.56M$154.80M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)PATHDOX
Cash & Equivalents i$700.64M$247.39M
Total Current Assets i$2.11B$1.56B
Total Current Liabilities i$715.87M$1.34B
Long-Term Debt i$73.43M$748.93M
Total Shareholders Equity i$1.70B$3.50B
Retained Earnings i$-2.01BN/A
Property, Plant & Equipment i$66.98M$874.85M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)PATHDOX
Operating Cash Flow i$195.89M$195.07M
Capital Expenditures i$-12.83M$-15.96M
Free Cash Flow i$106.17M$156.49M
Debt Repayment iN/AN/A
Common Stock Repurchase i$-227.53M$-135.24M

Short Interest & Institutional Ownership Analysis

MetricPATHDOX
Shares Short i52.29M4.41M
Short Ratio i4.115.21
Short % of Float i0.15%0.05%
Average Daily Volume (10 Day) i24,935,740959,580
Average Daily Volume (90 Day) i16,870,210866,193
Shares Outstanding i553.51M112.89M
Float Shares i417.19M107.73M
% Held by Insiders i0.09%0.00%
% Held by Institutions i0.82%0.99%

Dividend Analysis & Yield Comparison: Uipath vs Amdocs

MetricPATHDOX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A